Scientific Review Committee
Review Committee of
diabetes experts from
across the country
Diabetes Experts From
Across The Country
Each DRC research project undergoes a thorough vetting process for innovativeness
and scientific merit by our volunteer Scientific Review Committee, which is composed
of diabetes experts from across the country.
Domenico Accili, M.D.
Columbia University
Daniel Anderson, Ph.D.
Massachusetts Institute of Technology
Mark Anderson, M.D., Ph.D.
University of California, San Francisco
Peter Arvan, M.D., Ph.D.
University of Michigan Comprehensive Diabetes Center
Mark Atkinson, Ph.D.
University of Florida
Juan Carlos Belmonte, Ph.D.
Salk Institute
Ernesto Bernal-Mizrachi, M.D.
University of Miami
Anil Bhushan, Ph.D.
University of California, Los Angeles
Susan Bonner-Weir, Ph.D.
Harvard Stem Cell Institute
Peter Butler, M.D.
University of California, Los Angeles
Nigel Calcutt, Ph.D.
Board of Directors
Vincenzo Cirulli, M.D., Ph.D.
Board of Directors
Clark Colton, Ph.D.
Massachusetts Institute of Technology
Laura Crisa, M.D., Ph.D.
University of Washington
Tejal Desai, Ph.D.
University of California, San Francisco
Sangeeta Dhawan, Ph.D.
City of Hope
Adolfo Garcia-Ocaña, Ph.D.
Icahn School of Medicine at Mount Sinai
Tom Gardiner, M.D.
University of Michigan
Michael German, M.D.
University of California, San Francisco
George Gittes, M.D.
University of Pittsburgh Medical Center
John Glass, Ph.D.
J. Craig Venter Institute
David Gough, Ph.D.
University of California, San Diego
Dale Greiner, Ph.D.
University of Massachusetts
Michael Haller, M.D.
University of Florida
Anne Hanneken, M.D.
The Scripps Research Institute
Alberto Hayek, M.D.
Board of Directors
Matthias Hebrok, Ph.D.
University of California, San Francisco
Kevan Herold, M.D.
Yale University
Mark Huising, Ph.D.
School of MedicineUniversity of California, Davis
James D. Johnson, Ph.D.
University of British Columbia
Timothy Kern, Ph.D.
Case Western Reserve University
Charles C. King, Ph.D.
Board of Directors
Rohit Kulkarni, M.D.
Joslin Diabetes Center/Harvard Medical School
Jon Lakey, Ph.D.
University of California, Irvine
Jack Leahy, M.D.
University of Vermont
Amelia Linnemann, Ph.D.
University of Indiana School of Medicine
Aleksey Matveyenko, Ph.D.
Mayo Clinic
Raghu Mirmira, M.D., Ph.D.
University of Chicago
Charles Murtaugh, Ph.D.
University of Utah
Rama Natarajan, Ph.D. FAHA, FASN
Beckman Research Institute of City of Hope
Gerald Nepom, M.D., Ph.D.
Benaroya Research Institute
Christopher Newgard, Ph.D.
Duke University Medical Center
Feroz Papa, M.D., Ph.D.
University of California, San Francisco
Edward Phelps, Ph.D.
University of Florida
Athena Phylis-Tzimikas, M.D.
Scripps Whittier Diabetes Institute
Dave Piston, Ph.D.
University of Washington Medical School
Daniel Porte, M.D.
University of California, San Diego
Alvin Powers, Ph.D.
Vanderbilt University
Alberto Pugliese, M.D.
Diabetes Research Institute, University of Miami Medical School
Christopher Rhodes, Ph.D.
University of Chicago
Steve Rich, Ph.D.
University of Virginia
Camillo Ricordi, M.D.
University of Miami Diabetes Research Institute
Holger Russ, Ph.D.
Barbara Davis Center for Diabetes, University of Colorado- Anschutz Medical Campus
Maike Sander, M.D.
University of California San Diego
Nora Sarvetnick, Ph.D.
University of Nebraska
Ann-Marie Schmidt, M.D.
New York University
Peter Schultz, Ph.D.
The Scripps Research Institute
David Serreze, Ph.D.
Jackson Laboratories
Kumar Sharma, M.D.
University of Texas Health San Antonio
Robert Sorenson, Ph.D.
University of Minnesota
Peter Stock, M.D., Ph.D.
University of California, San Francisco
Doris Stoffers, M.D., Ph.D.
University of Pennsylvania Perelman School of MedicineÂ
Lori Sussel, Ph.D.
Barbara Davis Center for Diabetes, University of Colorado
Yo Suzuki, Ph.D.
J. Craig Venter Institute
Luc Teyton, M.D., Ph.D.
The Scripps Research Institute
Massimo Trucco, M.D.
Institute of Cellular Therapeutics, Allegheny Health Network
Rupangi Vasavada, Ph.D.
City of Hope
Matthias Von Herrath, M.D.
La Jolla Institute for Allergy and Immunology
Gordon Weir, M.D.
Joslin Diabetes Center/Harvard Medical School
Michael Weiss, M.D., Ph.D.
Indiana University School of Medicine
James Wells, Ph.D.
Wells Lab Research
Christopher Wright, Ph.D.
Vanderbilt University
Mark Yorek, Ph.D.
University of Iowa
Can the Inhibition of One Specific Body Gene Prevent Type 1 Diabetes? (Melanie Shapiro)
Taming a Particularly Lethal Category of Cells May Reduce/Eliminate the Onset of T1D (Dr. J. Dwyer)
A Potential Second Cure for T1D by Re-Educating the Patient’s Immune System (Dr. Leonardo Ferreira)
Stakeholder-Engaged Precision Health for Longevity and Healthy Aging with Type 1 Diabetes (T1D)
Dr. Han Zhu’s Project
Dr. Sandra Mara Ferreira’s Project
DRC has distributed approximately $3M to research
This funding has enabled key discoveries and advancements, showcasing our commitment to driving forward the research necessary to understand, manage, and ultimately cure this challenging condition.


We grant up to $75,000 to support each research project
#InnovativeDiabetesResearch
